ART induces cell cycle arrest in human prostate cancer, human gallbladder cancer, and human breast cancer cells by downregulating the expression of cyclin-dependent kinases CDK2 and CDK4 (81–83). The gene discussed is CDK2; the disease is prostate carcinoma.